The global Oncology Nutrition Market has been growing alongside the rising incidence of various forms of cancers amongst people. Diagnosis of cancer is followed up by a series of tests and therapies to control the disease from reaching the next stage. This has given an impetus to the growth of the global market for oncology nutrition by necessitating regular intake of food. Cancer patients are at a risk of suffering from disorders relating to improper nutrition due to their abysmal health condition.
The deteriorating situation of cancer-affected persons also worsens their natural appetite, and hence, the demand within the global market for oncology nutrition has been escalating. A number of advancements in the domain of oncology have led to the growth of the global market and has given rise to several forms of nutrition for cancer patients.
A report by TMR Research titled “Oncology Nutrition Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025” sheds light on the oncology nutrition market.
The need to effectuate homecare services for cancer patients has also created demand within the global market for oncology nutrition. The discovery of new kinds of cancers and their prevalence across a decent section of the population has created ripples in the global market. Hence, it is safe to estimate that the global market for oncology nutrition would expand at an astral rate over the years to come.
The market for oncology nutrition in North America has been growing on account of the large populace that travels to the US for treatment of cancer.
Some of the key players in the global market for oncology nutrition are Fresenius Kabi AG, and B, Nestle S.A., and Braun Melsungen AG.